Novel TB Regimen May Allow Shorter Treatment

Courtesy MedPage Today Infectious Disease  Thu, 04/02/2009 - 16:30

TORONTO (MedPage Today) -- Adding the fourth-generation fluoroquinolone moxifloxacin (Avelox) to standard tuberculosis therapy may allow treatment times to be shortened, an international study suggests.


 

More related items

'Totally' Resistant TB Surfaces in India
(MedPage Today) -- Drug resistance in tuberculosis appears to have reached a peak in several patients in India, who are virtually untreatable with available medications.

Shorter Combo TB Regimen Matches Standard Therapy...
(MedPage Today) -- A combination treatment for latent tuberculosis, delivered over three months, works as well as standard nine-month therapy with isoniazid, researchers reported.

TB Reaches Record Low in U.S.
(MedPage Today) -- The number of tuberculosis cases in the U.S. fell to an all-time low of 11,181 in 2010, according to the CDC.

Country Save HE Laundry Detergent, Powder, 160-Load,...

Yogi Tea Calm, Bedtime, Tea Bags, 16-Count Boxes...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
health-fitness.marc8.com